Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
PREDICTING TIME-TO-PAIN PROGRESSION IN KNEE OSTEOARTHRITIS: A CLINICAL AND RADIOMICS FEATURE ANALYSIS.
Journal: Osteoarthritis imaging
Published: August 20, 2026
Quality of Informed Consent via Telemedicine Compared With In-Person for Clinical Cancer Research.
Journal: JCO oncology practice
Published: June 16, 2025
Clinical Meaningfulness of an Algorithm-Based Service for Analyzing Treatment Response in Patients with Metastatic Cancer Using FDG PET/CT.
Journal: Journal of clinical medicine
Published: August 22, 2024
Clinical and Genomic Landscape of FGFR3-Altered Urothelial Carcinoma and Treatment Outcomes with Erdafitinib: A Real-World Experience.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 04, 2023
Reply to S. Zhang.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: May 24, 2022
Neoadjuvant Atezolizumab With Gemcitabine and Cisplatin in Patients With Muscle-Invasive Bladder Cancer: A Multicenter, Single-Arm, Phase II Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: January 28, 2022
The emerging role of antibody-drug conjugates in urothelial carcinoma.
Journal: Expert review of anticancer therapy
Published: June 20, 2020
Combined Vaccination with NY-ESO-1 Protein, Poly-ICLC, and Montanide Improves Humoral and Cellular Immune Responses in Patients with High-Risk Melanoma.
Journal: Cancer immunology research
Published: May 09, 2019
Current Status and Future Direction of Immunotherapy in Urothelial Carcinoma.
Journal: Current oncology reports
Published: February 27, 2019
Durable response to anti-PD-1 immunotherapy in epithelioid angiomyolipoma: a report on the successful treatment of a rare malignancy.
Journal: Journal for immunotherapy of cancer
Published: June 15, 2018
Adjuvant NY-ESO-1 vaccine immunotherapy in high-risk resected melanoma: a retrospective cohort analysis.
Journal: Journal for immunotherapy of cancer
Published: December 27, 2017
Primary Melanoma Histologic Subtype: Impact on Survival and Response to Therapy.
Journal: Journal of the National Cancer Institute
Published: December 20, 2017
Last Updated: 09/26/2026